← Open Payments lookup

CRYSTAL CLARK-CROOKSHANKS: Open Payments

NPI 1942567763 · SUMMERSVILLE, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,121 in 81 payments from 14 companies in 2025. Trend: 2023 $302 · 2024 $1,088 · 2025 $1,121

Food & beverage: $1,121
CompanyPaymentsAmount
ABBVIE INC.32$279
Neurocrine BioSciences, Inc.11$193
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$144
E.R. Squibb & Sons, L.L.C.5$106
Gilead Sciences, Inc.5$84
Otsuka America Pharmaceutical, Inc.4$80
Teva Pharmaceuticals USA, Inc.2$48
Alkermes, Inc.2$45
Indivior Inc.2$39
Takeda Pharmaceuticals U.S.A., Inc.1$31

Products named: VRAYLAR, INGREZZA, CAPLYTA, COBENFY, MAVYRET, REXULTI, UZEDY, SUBLOCADE.

Industry payments across WV — which companies pay providers there.